Researchers investigated the role of proprotein convertase subtilisin kexin type 9 (PCSK9) and explored the therapeutic effect of metformin for olanzapine-associated non-alcoholic fatty liver disease.
[Scientific Reports]
Sorry, but the selected Zotpress account can't be found.